YURAK KASALLIKLARI VA SARATON O‘RTASIDAGI BOG‘LIQLIKLAR
Keywords:
yurak kasalliklari, saraton, xavf omillari, kardiotoksiklikAbstract
Ushbu maqolada yurak-qon tomir kasalliklari va saraton o‘rtasidagi bog‘liqliklar ko‘rib chiqilgan. Tadqiqotlar shuni ko‘rsatadiki, ushbu ikki kasallik bir-biriga ta’sir qilishi mumkin, chunki ular umumiy xavf omillariga ega. Bundan tashqari, saratonni davolashda qo‘llaniladigan kimyoterapiya va radioterapiya yurak faoliyatiga salbiy ta’sir ko‘rsatishi mumkin. Mazkur maqolada asosiy xavf omillari, klinik kuzatuvlar va ilmiy adabiyotlar asosida ularning o‘zaro bog‘liqligi yoritilgan.
References
1. Xolmatov A., To‘xtasinov R. Kardiologiya asoslari. Toshkent: Tibbiyot nashriyoti, 2018.
2. Karimov B. Onkologiya va klinik amaliyot. Toshkent: Fan va texnologiya, 2020.
3. Herrmann J. Cardiovascular toxicities of cancer therapies: current issues in cardio-oncology. European Heart Journal. 2020;41(35):3892–3900.
4. Koene RJ, Prizment AE, Blaes A, Konety SH. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133(11):1104–1114.
5. Armenian SH, Xu L, Ky B, Sun C, Farol LT, Pal SK. Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study. J Clin Oncol. 2016;34(10):1122–1130.
6. Curigliano G, Cardinale D, Dent S, Criscitiello C, Aseyev O, Lenihan D. Cardiotoxicity of anticancer treatments: epidemiology, detection, and management. CA: A Cancer Journal for Clinicians. 2016;66(4):309–325.
7. Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity. European Heart Journal. 2016;37(36):2768–2801.
8. Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J. 2019;40(48):3889–3897.
